News Snapshot:
The experiemental COVID-19 vaccine co-developed by the U.S.’s Pfizer , Germany’s BioNTech, and China’s Fosun Pharmaceuticals may reach market as early as this December, according to the chairman of Fosun Group. “Once the vaccine is proved to be safe and effective [after trial results are posted in November], the vaccine will be made available in the market by December [2020] or January next year,†Guo Guangchang, chair of the parent company of Fosun Pharmaceuticals, said Tuesday at the Fortune Global Forum. There is, of course, no guarantee that the vaccine is safe and effective enough for mass distribution. Pfizer, BioNTech,...
